Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sho-saiko-to in Chronic Hepatitis C
NCT00590564Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Oct 2002
- Primary completion
- Feb 2011
- Modality
- Herbal formula
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Xiao Chai Hu Tang in hepatitis C (HCV), sponsored by Memorial Sloan Kettering Cancer Center. Primary endpoint: Improvement in Hepatic Injury on Liver Histology at 52 weeks. Started Oct 2002; status: completed.
02
Drugs
Xiao Chai Hu Tang
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00590564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00590564.